Funding will support the company to achieve first-in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company and spinout from Oxford University, is developing a treatment for brain aneurysms, that will overcome challenges with existing medical devices. It has just raised $10m in a series A funding round. The funding […]
Press Release: Oxford, UK, 14th November 2020. Oxford Endovascular Ltd, the developer of advanced neurovascular technologies to save lives of patients suffering from brain aneurysms has been awarded non-dilutive grant funding of £350,000 match funded by the company with £150,000 via the prestigious Smart Grant Program run by Innovate UK, the UK’s innovation agency* […]
Following extensive due diligence by medical, industry, and investor experts, Oxford Endovascular is selected as one of Europe’s top start-ups to be supported by the EIT Health Rescue Instrument. Download the attachment: Start-up Rescue press release FINAL 07.08.20
This kick starts the company’s next fundraise to take it to first in human clinical data. See the RESI landing page for a company update & for delegates at RESI to vote on: https://resiconference.com/digital-resi-june-2020-agenda/innovation-challenge-oxford-endovascular-ltd/
‘Next Generation Flow Diverter for the Treatment of Intracranial Aneurysms Delivering Improved Patient Outcomes and Healthcare Cost Savings — OXIFLOW’ This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 859001 Mike Karim, CEO, commented: ‘We are delighted to have won this prestigious grant […]
The Birth of Oxford Endovascular – Interview with Beth Suzanne.
Oxford Endovascular kick starts its next fund raise following strong pre-clinical results
Oxford Endovascular in GLP phase with its brain aneurysm treatment device Oxford Endovascular Limited CEO Mike Karim spoke with Proactive Investors at the Biotech Showcase in San Francisco.
Oxford Endovascular, a spin-out from Oxford University, has used ‘origami engineering for the brain’ to develop a unique, patented, next-generation flow-diverter (OxiFlow) for the minimally invasive treatment of intracranial aneurysms – a market around $1 Billion, 8% CAGR. The device has been designed by world leading Professors of Medicine & Engineering. OxiFlow, is inserted via […]